跳至主要内容
临床试验/NCT02640586
NCT02640586进行中(未招募)不适用

Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI

Sun Ying-Shi11 个研究点 分布在 1 个国家目标入组 1,614 人开始时间: 2016年1月10日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
1,614
试验地点
11
主要终点
Predictive value of eary MRI (14-16 days MRI) for assessing pathological complete response(pCR) at surgery

研究概览

简要总结

The purpose of this study is to investigate if MRI scans performed after neoadjuvant radiotherapy can predict the therapeutic response of rectal cancer following preoperative chemo-radiotherapy. This will help doctors to better tailor treatments for rectal cancer in the future.

详细描述

We proposed to constructed multi-parameter predictive model for predicting therapeutic response and pathological complete response(pCR) of patients with rectal cancer who received neoadjuvant chemoradiation. MR radiomics,convolutional neural networks, morphological parameters and quantitative functional parameters derived from diffusion-weighted MR images will be integrated for model construction.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • T3/4 or node positive biopsy-proved primary rectal cancer
  • Suitable for pre-operative chemoradiotherapy and surgical resection
  • No contraindication to MRI
  • Ability to understand and the willingness to sign a written informed consent document

排除标准

  • History or concurrent of other cancer
  • Previous therapy to pelvis
  • Unable/unwilling to have MRI
  • Pacemaker or implanted defibrillator
  • Pregnancy, lactation or inadequate contraception
  • Patients with a history of psychological illness or condition such as to interfere with the patient's ability to understand requirements of the study
  • Unwilling or unable to give informed consent

结局指标

主要结局

Predictive value of eary MRI (14-16 days MRI) for assessing pathological complete response(pCR) at surgery

时间窗: 2 years

A scoring system for predicting pCR will be developed based on MRI parameters and their changes between baseline and early MRI. No viable cancer cells seen in the resection specimen is regarded as pCR

Predictive value of preoperative MRI(7-9 weeks after the completion of preoperative chemo-radiotherapy) for assessing pCR

时间窗: 2 years

A scoring system for predicting pCR will be developed based on MRI parameters

次要结局

  • Predictive value of eary MRI (14-16 days after initiation of preoperative radio-chemotherapy) for assessing pathological response according to Tumour Regression Grade (TRG)(2 years)
  • Feasibility of conducting MRI scans at 7-9 weeks after preoperative radio-chemotherapy(2 years)
  • MRI-predicted pCR and MRI-predicted response on long-term disease control and survival(3 years)
  • Predictive value of preoperative MRI(7-9 weeks after the completion of preoperative chemo-radiotherapy) for assessing pathological response according to Tumour Regression Grade (TRG)(2 years)

研究者

发起方
Sun Ying-Shi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sun Ying-Shi

Chairman of Department of Radiology

Peking University Cancer Hospital & Institute

研究点 (11)

Loading locations...

相似试验